Importantly, PRSS3/MTG linked to F2RL1 (also known as PAR2), was reported to modulate inflammation and tumorigenesis in several cancer types, such as colon cancer and breast cancer (23, 24). Here, PRSS3 is linked to malignant colon neoplasm.